Research Project

Project Title:	OL Extension Study of LNP023 in C3G
Project Type:	Clinical Trial, Enrolment terminated
Disease group(s):	Immune glomerulopathies
Project Summary:	This is an open-label extension study to evaluate the long-term efficacy, safety and tolerability of LNP023 in subjects with C3 glomerulopathy.
Lead principal investigator(s):	,
Co-investigator(s):	Erica Daina, Bergamo
Project Period:	01/2020 - 12/2028